WatchGuard’s XDR Solution, ThreatSync, Simplifies
ThreatSync enables a comprehensive and simple-to-use XDR solution as part of WatchGuard’s Unified Security Platform, accelerating cross-product detections......
LegalZoom to Participate in Upcoming Investor Conferences
GLENDALE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (Nasdaq: LZ) today announced its participation in the JMP Securities Technology......
Molecular Templates Announces Participation in Upcoming
AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage......
Nature’s Sunshine Sets Fourth Quarter and Full Year 2022
LEHI, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nature’s Sunshine) (NASDAQ: NATR), a leading natural health and wellness......
Sana Biotechnology to Present at the Cowen 43rd Annual
[img]https://ml.globenewswire.com/Resource/Download/86b7f0b7-b317-402a-b600-8a26860a948e?size=1[/img]SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells...
Key Financial to Hold Tax Document Paper Shredding Event on
WEST CHESTER, Pa., March 01, 2023 (GLOBE NEWSWIRE) -- Key Financial, Inc., a Barron’s and Forbes nationally recognized wealth management firm in West......
Noble Capital Markets Annual Investor Conference - NobleCon
Boca Raton, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- In a joint statement, Noble Capital Markets, Inc. (“Noble”) and Florida Atlantic......
NGM Bio to Participate in the Cowen 43rd Annual Health Care
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on......
Xometry Reports Fourth Quarter and Full Year 2022 Results
Q4 revenue increased 46% year-over-year driven by solid marketplace growth of 32% as well as supplier services including the acquisition of Thomas Q4......
Kineta Appoints Internationally-Renowned Clinical
SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation......